MediPharm Labs Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
David Pidduck
Chief executive officer
CA$3.6m
Total compensation
| CEO salary percentage | 8.6% |
| CEO tenure | 2yrs |
| CEO ownership | 3.1% |
| Management average tenure | 3.9yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Market Might Still Lack Some Conviction On MediPharm Labs Corp. (TSE:LABS) Even After 31% Share Price Boost
Mar 23
Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?
Jan 10MediPharm Labs (TSE:LABS) Has Debt But No Earnings; Should You Worry?
Sep 06MediPharm Labs Corp. (TSE:LABS) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 17Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook
Aug 20Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates
May 21Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade
Apr 06Is MediPharm Labs (TSE:LABS) Using Too Much Debt?
Mar 07Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?
Aug 18Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates
May 23Reflecting on MediPharm Labs' (TSE:LABS) Share Price Returns Over The Last Year
Jan 11
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CA$13m |
| Sep 30 2023 | n/a | n/a | -CA$16m |
| Jun 30 2023 | n/a | n/a | -CA$19m |
| Mar 31 2023 | n/a | n/a | -CA$26m |
| Dec 31 2022 | CA$4m | CA$315k | -CA$30m |
Compensation vs Market: David's total compensation ($USD2.67M) is above average for companies of similar size in the Canadian market ($USD174.90K).
Compensation vs Earnings: Insufficient data to compare David's compensation with company performance.
CEO
David Pidduck
2yrs
Tenure
CA$3,641,903
Compensation
Mr. David A. Pidduck is Chief Executive Officer and President of MediPharm Labs Corp. since April 20, 2022. Mr. Pidduck has been the Chief Executive Officer and President of Purdue Pharma Inc. since Septem...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2yrs | CA$3.64m | 3.11% CA$ 1.0m | |
| Co-Founder & President | 5.2yrs | CA$1.07m | 0.51% CA$ 164.0k | |
| Chief Financial Officer | 3.2yrs | CA$1.20m | 0.21% CA$ 68.2k | |
| Founder | 9.3yrs | CA$858.16k | no data | |
| Vice President of Operations & Supply Chain | 3.3yrs | no data | no data | |
| Executive VP & General Counsel | no data | no data | no data | |
| Vice President of Sales | 3.9yrs | no data | no data | |
| Executive Vice President of Global Accounts | 5.2yrs | no data | no data |
3.9yrs
Average Tenure
Experienced Management: LABS's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2yrs | CA$3.64m | 3.11% CA$ 1.0m | |
| Independent Director | 3.8yrs | CA$51.30k | no data | |
| Independent Director | less than a year | no data | 0.029% CA$ 9.3k | |
| Independent Chairman of the Board | 3.8yrs | CA$40.50k | 0.25% CA$ 80.0k | |
| Member of the Science Advisory Board | 5yrs | CA$40.50k | 0% CA$ 0 | |
| Member of the Science Advisory Board | 5yrs | no data | no data | |
| Member of the Science Advisory Board | 5yrs | no data | no data | |
| Member of the Science Advisory Board | 5yrs | no data | no data | |
| Member of the Science Advisory Board | 5yrs | no data | no data | |
| Member of the Science Advisory Board | 5yrs | no data | no data | |
| Member of the Science Advisory Board | 4.7yrs | no data | no data | |
| Independent Director | 3.7yrs | CA$40.50k | 0.021% CA$ 6.9k |
4.8yrs
Average Tenure
Experienced Board: LABS's board of directors are considered experienced (4.8 years average tenure).